10 completed, 5 unknown, 2 active not recruiting, 2 recruiting. 21 Phase 2, 3 Phase 3, 2 Phase 1.
Follow Bronchial Asthma: new trials by email Literature Review of Bronchial Asthma trials Research Report on Bronchial Asthma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study on the Safety and Efficacy of PA9159 Inhalation Aerosol for the Treatment of Adult Bronchial Asthma PA9159 Metered-Dose Inhaler, 120 μg per day for 28 days, Fluticasone Propionate Inhaled Aerosol 200 μg per day for 28 days - Bronchial Asthma | Phase 2 | Recruiting | Anhui Palo Alto Pharmaceuticals, Inc. | 30 | 2025-10-15 | 2026-01-07 |
| Study of MG-ZG122 Humanized Monoclonal Antibody in Asthma Subjects MG-ZG122 Humanized Monoclonal Antibody Injection, Placebo - Bronchial Asthma | Phase 2 | Active not recruiting | Shanghai Mabgeek Biotech.Co.Ltd | 160 | 2025-05-11 | 2025-07-08 |
| Safety and Efficacy of PA9159 Inhalation Aerosol for the Treatment of Adult Bronchial Asthma PA9159 Metered-Dose Inhaler, 60 μg per day for 28 days, PA9159 Metered-Dose Inhaler, 120 μg per day for 28 days, PA9159 Metered-Dose Inhaler, 240 μg per day for 28 days - Bronchial Asthma | Phase 2 | Recruiting | Anhui Palo Alto Pharmaceuticals, Inc. | 60 | 2025-02-24 | 2026-01-08 |
| Oral Intake of Mg in Controlled Asthmatic Patients Magnesium, ICS+LABA - Bronchial Asthma | Phase 2 / Phase 3 | Active not recruiting | Zagazig University | 166 | 2024-11-02 | 2025-08-14 |
| A Study to Evaluate the Efficacy and Safety of HSK31858 Tablets in Patients with Bronchial Asthma HSK31858, Placebo - Bronchial Asthma | Phase 2 | Enrolling by invitation | Haisco Pharmaceutical Group Co., Ltd. | 219 | 2024-10-22 | 2024-12-24 |
| XC8 in the Treatment of Patients With the Eosinophilic Phenotype of Bronchial Asthma XC8 100 mg, Placebo - Bronchial Asthma, Eosinophilic Asthma | Phase 2 | Completed | Chemlmmune Therapeutics LLC | 70 | 2020-12-16 | 2021-09-22 |
| A Clinical Study on the Prevention of Mild to Moderate Intermittent Asthma With Chinese Medicine Weiyang Yuping Fang Weiyang Yuping Fang - Bronchial Asthma | Phase 2 | Unknown | Shanghai University of Traditional Chinese Medicine | 84 | 2020-10-01 | 2023-05-25 |
| Mechanistic Study of Anti-inflammatory Effects of Fevipiprant in Patients With Eosinophilic Asthma. QAW039 - Asthma, Asthma, Bronchial | Phase 2 | Withdrawn | Novartis Pharmaceuticals | 2019-10-15 | 2020-05-14 | |
| Clinical Study on Treatment of Chronic Persistent Bronchial Asthma Ke Chuan Liu Wei Granule, Yang He Ping Chuan Granule, Ke Chuan Liu Wei Granule placebo - Bronchial Asthma | Phase 2 | Unknown | Shanghai University of Traditional Chinese Medicine | 320 | 2018-02-01 | 2023-05-25 |
| A Study to Assess Jia Wei Yang He Formula as a Plus Therapy in the Treatment of Persistent Asthma Jia Wei Yang He granule, Jia Wei Yang He granule Placebo - Bronchial Asthma | Phase 2 | Unknown | Shanghai University of Traditional Chinese Medicine | 240 | 2017-10-01 | 2024-05-07 |
| Study on the Treatment of Bronchial Asthma With Traditional Chinese Medicine Ke Chuan Liu Wei Mixture, Chuan Xiong Ping Chuan Mixture, Xie Wu Capsule - Bronchial Asthma | Phase 2 | Unknown | Shanghai University of Traditional Chinese Medicine | 288 | 2017-07-30 | 2020-02-26 |
| XC8 in the Treatment of Patients With Bronchial Asthma XC8 Oral Tablet, Placebo Oral Tablet - Bronchial Asthma | Phase 2 | Completed | PHARMENTERPRISES LLC | 120 | 2016-09-20 | 2018-03-01 |
| Omalizumab in Non-atopic Asthma Omalizumab, Placebo - Bronchial Asthma | Phase 2 / Phase 3 | Unknown | King's College London | 40 | 2010-04-01 | 2011-01-21 |
| A Study to Assess Safety and Efficacy of a Novel Treatment, Keratinocyte Growth Factor (KGF), in Asthmatic Patients Keratinocyte Growth factor, Saline placebo - Bronchial Asthma | Phase 2 | Completed | University Hospital Southampton NHS Foundation Trust | 24 | 2009-08-01 | 2016-10-13 |
| Treatment of Bronchial Asthma With Borage and Echium Seed Oils Borage Seed Oil and Echium Seed Oil, Corn Oil - Bronchial Asthma | Phase 1 / Phase 2 | Completed | Brigham and Women's Hospital | 43 | 2008-12-01 | 2017-07-03 |
| Research on Traditional Chinese Medicine (TCM) Clinical Treatment of the Acute Episode of Bronchial Asthma. warming lung and relieving asthmatic granule and Securing origin and warming lung emplastrum, clearing lung and relieving asthmatic granule and securing origin and clearing lung emplastrum, securing origin and relieving asthmatic granule and securing origin and nourishing lung emplastrum - Bronchial Asthma | Phase 2 | Completed | Liaoning University of Traditional Chinese Medicine | 360 | 2008-12-01 | 2011-02-11 |
| A Study to Assess the Efficacy of Inhaled Corticosteroid (ICS) Therapy in Moderate-Severe Bronchial Asthma inhaled corticosteroid therapy - Bronchial Asthma | Phase 1 / Phase 2 | Completed | Novartis | 26 | 2006-07-01 | 2007-06-22 |
| OC000459 Bronchial Allergen Challenge OC000459, Placebo - Bronchial Asthma | Phase 2 | Completed | Oxagen Ltd | 20 | 2006-02-01 | 2010-01-26 |
| Efficacy and Safety of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 70 y) (APTA-2217-05). Roflumilast - Bronchial Asthma | Phase 2 / Phase 3 | Completed | AstraZeneca | 450 | 2004-05-01 | 2026-06-10 |
| Dose Response of Inhaled Tacrolimus in Patients With Moderate Persistent Asthma tacrolimus - Asthma, Bronchial, Bronchial Asthma | Phase 2 | Completed | Astellas Pharma Inc | 370 | 2008-04-17 |
Showing 20 of 21. Sign in to see all of them.
Asthma (21) · Respiratory Aspiration (2) · Eosinophilia (1) · Hypersensitivity (1) · Inflammation (1) · Pulmonary Eosinophilia (1)
Bronchial Diseases (21) · Hypersensitivity, Immediate (21) · Immune System Diseases (21) · Lung Diseases (21) · Lung Diseases, Obstructive (21) · Respiratory Hypersensitivity (21) · Respiratory Tract Diseases (21) · Hypersensitivity (20) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Leukocyte Disorders (2) · Respiration Disorders (2) · Eosinophilia (1)
Tacrolimus (2) · histamine glutarimide (2) · (5-fluoro-2-methyl-3-quinolin-2-ylmethylindo-1-yl)acetic acid (1) · Corn Oil (1) · Fibroblast Growth Factor 7 (1) · Magnesium (1) · Omalizumab (1) · Roflumilast (1) · borage oil (1) · fevipiprant (1)
Shanghai University of Traditional Chinese Medicine (4) · Anhui Palo Alto Pharmaceuticals, Inc. (2) · Astellas Pharma Inc (2) · AstraZeneca (1) · Brigham and Women's Hospital (1) · Chemlmmune Therapeutics LLC (1) · Haisco Pharmaceutical Group Co., Ltd. (1) · King's College London (1) · Liaoning University of Traditional Chinese Medicine (1) · Novartis (1) · Novartis Pharmaceuticals (1) · Oxagen Ltd (1) · PHARMENTERPRISES LLC (1) · Shanghai Mabgeek Biotech.Co.Ltd (1) · University Hospital Southampton NHS Foundation Trust (1)
China (8) · Russia (4) · Germany (3) · United Kingdom (3) · Czechia (2) · Poland (2) · Ukraine (2) · Bulgaria (1) · Egypt (1) · Hungary (1) · Japan (1) · United States (1)
Wei Zuo (2) · Zhenhui Lu, Doctor (2) · Christopher Corrigan, MD, PhD (1) · David Singh, MD (1) · Elliot Israel, MD (1) · Huiyong Zhang, Director (1) · Huiyong Zhang, Master (1) · Neil Barnes, MD (1) · Peter H Howarth, BSc, MBBS (1) · Prathap Pillai, MD (1) · R.G.M.vom Amsterdam, MD (1)
PMID 22496329, PMID 25485197, PMID 27824606, PMID 29973284, PMID 33095411
2009 (1), P50AT002782 (1)